Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases
ConclusionsThis retrospective study shows that bevacizumab has efficacy and favorable toxicity in patients with NSCLC and brain metastases and cardiovascular disease might be a risk factor for cerebral toxicity.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Avastin | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Ischemic Stroke | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Stroke | Study | Toxicology